To our knowledge, this is the first study to present evidence of the association between renal resistance to the phosphaturic actions of FGF23, but not to PTH-driven phosphaturia, and the degree of AAC in patients CKD-stages 3 and 4. The gene discussed is FGF23; the disease is chronic kidney disease.